DE LUCA, Giampiero,YTHIER, Arnaud,MUNAFO, Alain,LOPEZ-BRESNAHAN, Maria
申请号：
MEP3512
公开号：
ME01333B
申请日:
2005.12.20
申请国别(地区):
ME
年份:
2013
代理人:
摘要：
The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.
